Tyson Foods Inc., a leading global meat processor, has announced it will remove the "No Antibiotics Ever" label from select chicken products, reintroducing antibiotics not significant to human treatment. This policy shift has raised eyebrows, given the growing concern about antibiotic resistance fueled by food production practices.
Tyson Foods ditched the drug for infections eight years ago, and since then, the “no antibiotics ever” has been emblazoned on its chicken products’ label packaging. Then again, only some of the chicken items are set to lose the mentioned phrase on the label.
According to CNN Business, the Springdale, Arkansas-based food processing company will start using antibiotics in its chicken production and said that this is the type that is not important to the treatment of humans. In any case, the use of antibiotics in food production or processing has been heavily scrutinized in recent years because some bacteria have become resistant to medicines and treatment due to repeated exposure to antibiotics.
“At Tyson Foods, we base our decisions on sound science and an evolving understanding of the best practices impacting our customers, consumers, and the animals in our care,” the spokesperson of Tyson Foods said in a statement.
The company said that some of its chicken would start deleting the “no antibiotics important to human medicine” on the label by the end of this year. Tyson Foods ascertained it would only apply antibiotics that are up to the standard and recognized by the USDA and the World Health Organization (WHO).
It was in 2015 when the company announced its decision to eliminate the antibiotics in its chicken wings, breast, and chicken nuggets. At the time, the company said it was working to get rid of the drug as it was worried about the increase in antibiotic-resistant bacterial infections in humans. It added that it would like to play its part in helping reduce the human consumption of antibiotics.
Meanwhile, The Wall Street Journal was the first to report on Tyson Foods’ decision to resume its use of non-medically important antibiotics in some of its chicken production. “Based on current science, Tyson brand products are transitioning to No Antibiotics Important to Human Medicine (NAIHM), which is expected to be complete by the end of the calendar year,” the company’s representative stated.


Gulf War Ceasefire Hopes Weigh on Dollar Ahead of Trump Address
Russell 1000 Companies Hit $2.2T Cash Record While Aggressively Reinvesting in Growth
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
MATCH Act Targets ASML and Chinese Chipmakers in New U.S. Export Crackdown
Japan's Services Sector Growth Slows in March Amid Rising Middle East Tensions
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
KPMG UK Cuts 440 Audit Jobs Amid Low Attrition and Cooling Professional Services Demand
March 2025 Jobs Report: Strong Headline Numbers Hide Deeper Economic Concerns
Apple Turns 50: From Garage Startup to AI Crossroads
Japan Signals Readiness to Intervene as Yen Weakens Toward 160 Per Dollar
Trump Claims Iran Sought Ceasefire as Middle East War Escalates
Cathay Pacific Holds Firm on Flight Capacity Amid Middle East Conflict and Rising Fuel Costs
Trump's Iran War Speech Sparks Market Anxiety Over Extended Conflict
Trump Threatens Escalation Against Iran, Warns of Infrastructure Strikes
Trump's Claim That the U.S. Can Cover Global Jet Fuel Shortfall Doesn't Add Up
First Western Ship Transits Strait of Hormuz Since Iran War Began
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition 



